Physician profile
Eva Pilchman
NPI 1427313907
$2,631.66
in general payments reported to CMS, 2019-2025
13 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $996 · 2022: $717 · 2023: $250 · 2024: $290 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,136.92 | 2021-2025 | Signia, Ligasure, Sonicision |
| Intra-Sana Laboratories | $417.16 | 2021 | |
| Redhill Biopharma INC. | $350.78 | 2021-2023 | Talicia, Aemcolo, Movantik |
| Novo Nordisk INC | $140.57 | 2022-2024 | Wegovy |
| Teleflex LLC | $135.29 | 2022 | |
| Lilly USA, LLC | $118.71 | 2025 | Zepbound |
| Intuitive Surgical, INC. | $95.66 | 2021 | |
| W. L. Gore & Associates, INC. | $86.09 | 2021 | |
| Endo Pharmaceuticals INC. | $42.43 | 2021-2022 | |
| Vivus LLC | $39.54 | 2021-2024 | Qsymia |
| Currax Pharmaceuticals LLC | $32.60 | 2021-2022 | |
| Standard Bariatrics, INC. | $22.02 | 2022 | |
| Daiichi Sankyo INC. | $13.89 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Pilchman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.